Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
Alliance, Array, attack, batch, binimetinib, Brain, Breast, CABOSUN, cavity, certainty, Congressional, cyber, divided, ecorafenib, enthusiasm, epithelial, error, expedite, expiry, facilitate, fallopian, forecast, hacker, halted, harder, heavily, Heng, hierarchy, ingredient, inspection, intermediate, IV, leadership, Lymph, malfeasance, mCRPC, Mirati, Month, mRCC, Neoadjuvant, Node, nominal, occupying, ovarian, overlap, paclitaxel, Palpable, passing, payer, PDUFA, peritoneal, persistent, poor, prepaid, preservation, prevalent, priority, raw, recurrent, relieve, remediation, rent, REPOSIT, repricing, routine, similarly, Simplifying, sophistication, sustain, tactical, tube, unmet, unvested, usage, vacant, wide, worldwide, Zelboraf
Removed:
administered, Affordability, Algeta, androgen, ascertain, Assessment, attained, Biotech, blinding, bone, cabazitaxel, calculating, chemotherapeutic, conclusion, considerably, context, curtail, damaged, death, declared, decrement, depreciation, diagnosed, differentiated, discontinuation, discontinue, docetaxel, dosage, eighteen, encouraging, enzalutamide, ethically, EXAM, final, foretinib, hiring, Human, incidence, intent, internally, invoiced, Janssen, judgment, lengthier, lesser, mediated, medicinal, Medivation, mitoxantrone, mix, modest, notably, NPU, October, onartuzumab, opioid, palliation, partnership, payor, placebo, population, potent, practically, presence, proceed, profile, protocol, radium, recommended, registered, remeasure, request, returned, scan, science, securing, shelf, SPA, subjective, supported, tolerability, transition, translate, unattractive, underwriting, underwritten, unfavorable, unpartnered, utilizing, vacate, wage, wholesale, wind
Filing tables
Filing exhibits
- 10-Q Quarterly report
- 12.1 Statement Re Computation of Earnings to Fixed Charges
- 31.1 Certification of CEO Required by Rule 13A-14(A) or Rule 15D-14(A)
- 31.2 Certification of CFO Required by Rule 13A-14(A) or Rule 15D-14(A)
- 32.1 Certification of CEO and CFO Required by Rule 13A-14(B) or Rule 15D-14(B)
- Download Excel data file
- View Excel data file
Related press release
EXEL similar filings
Filing view
External links